Evidence map›Paper›PMID 29794156›Full record

ArticleEMBO reports2018

The β3-integrin endothelial adhesome regulates microtubule-dependent cell migration.

Samuel J Atkinson, Aleksander M Gontarczyk, Abdullah Aa Alghamdi, Tim S Ellison, Robert T Johnson, Wesley J Fowler, Benjamin M Kirkup, Bernardo C Silva, Bronwen E Harry, Jochen G Schneider and 6 more

Open access · hybridAbstract read
In one paragraph

Article in EMBO reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 4 countries.

Samuel J AtkinsonSchool of Biological Sciences, Norwich Research Park, University of East Anglia, Norwich, UK.
Aleksander M GontarczykSchool of Biological Sciences, Norwich Research Park, University of East Anglia, Norwich, UK.
Abdullah Aa AlghamdiSchool of Biological Sciences, Norwich Research Park, University of East Anglia, Norwich, UK.
Tim S EllisonSchool of Biological Sciences, Norwich Research Park, University of East Anglia, Norwich, UK.
Robert T JohnsonSchool of Biological Sciences, Norwich Research Park, University of East Anglia, Norwich, UK.
Wesley J FowlerSchool of Biological Sciences, Norwich Research Park, University of East Anglia, Norwich, UK.
Benjamin M KirkupSchool of Biological Sciences, Norwich Research Park, University of East Anglia, Norwich, UK.
Bernardo C SilvaSchool of Biological Sciences, Norwich Research Park, University of East Anglia, Norwich, UK.
Bronwen E HarrySchool of Biological Sciences, Norwich Research Park, University of East Anglia, Norwich, UK.
Jochen G SchneiderLuxembourg Center for Systems Biomedicine (LCSB), Luxembourg & Saarland University Medical Center, Internal Medicine II, University of Luxembourg, Homburg, Germany.
Katherine N WeilbaecherDivision of Molecular Oncology, Department of Internal Medicine, Washington University in St Louis, St. Louis, MO, USA.
Mette M MogensenSchool of Biological Sciences, Norwich Research Park, University of East Anglia, Norwich, UK.
Mark D BassDepartment of Biomedical Science, Centre for Membrane Interactions and Dynamics, University of Sheffield, Sheffield, UK.
Maddy ParsonsRandall Division of Cell and Molecular Biophysics, King's College London, New Hunt's House, Guys Campus, London, UK.ORCID 0000-0002-2021-8379
Dylan R EdwardsFaculty of Medicine and Health Sciences, Norwich Research Park, University of East Anglia, Norwich, UK.
Stephen D RobinsonSchool of Biological Sciences, Norwich Research Park, University of East Anglia, Norwich, UK stephen.robinson@uea.ac.uk.ORCID 0000-0002-6606-7588
University of East Anglia · GBCentre Hospitalier de Luxembourg · LUKing's College London · GBUniversity of Sheffield · GBWashington University in St. Louis · US

Funding

Biotechnology and Biological Sciences Research Council BB/J009040/1Biotechnology and Biological Sciences Research Council BB/J014524/1Biotechnology and Biological Sciences Research Council BB/M011216/1British Heart Foundation PG/15/25/31369Wellcome Trust 088419
6 · The paper itself

Abstract

Integrin β3 is seen as a key anti-angiogenic target for cancer treatment due to its expression on neovasculature, but the role it plays in the process is complex; whether it is pro- or anti-angiogenic depends on the context in which it is expressed. To understand precisely β3's role in regulating integrin adhesion complexes in endothelial cells, we characterised, by mass spectrometry, the β3-dependent adhesome. We show that depletion of β3-integrin in this cell type leads to changes in microtubule behaviour that control cell migration. β3-integrin regulates microtubule stability in endothelial cells through Rcc2/Anxa2-driven control of active Rac1 localisation. Our findings reveal that angiogenic processes, both

Indexed as

AnimalsAnnexin A2Cell AdhesionCell MovementChromosomal Proteins, Non-HistoneEndothelial CellsEndothelium, VascularGene Expression RegulationHumansIntegrin beta3Mass SpectrometryMiceMicrotubulesNeoplasmsNeovascularization, Pathologicrac1 GTP-Binding ProteinAnnexin A2ANXA2 protein, humanChromosomal Proteins, Non-HistoneIntegrin beta3rac1 GTP-Binding ProteinRcc2 protein, mouseadhesomeendothelialintegrinsmicrotubules

Identifiers

PMID29794156
PMCPMC6030693
OpenAlexW2950590924

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.